We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.31B
AUM Growth
-$78.9M
Cap. Flow
-$105M
Cap. Flow %
-7.96%
Top 10 Hldgs %
6.88%
Holding
1,081
New
330
Increased
200
Reduced
286
Closed
229

Top Sells

Rank Stock Value
1
MDB icon
MongoDB
MDB
+$7M
2
CRL icon
Charles River Laboratories
CRL
+$6.37M
3
FND icon
Floor & Decor
FND
+$5.83M
4
BRKR icon
Bruker
BRKR
+$5.34M
5
ASAN icon
Asana
ASAN
+$5.32M

Sector Composition

Rank Sector Weight
1 Technology 24.86%
2 Healthcare 21.49%
3 Industrials 12.78%
4 Consumer Discretionary 11.8%
5 Financials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNKD icon
776
MannKind Corp
MNKD
$1.2B
$184K 0.01%
+42,161
New +$195K
EXTN
777
DELISTED
Exterran Corporation
EXTN
$184K 0.01%
61,700
-1,900
-3% -$7.53K
NXGN
778
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$183K 0.01%
+10,300
New +$165K
VWTR
779
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$176K 0.01%
14,560
-3,040
-17% -$36.7K
TCDA
780
DELISTED
Tricida, Inc. Common Stock
TCDA
$175K 0.01%
18,296
-17,800
-49% -$115K
FOA icon
781
Finance of America Companies
FOA
$215M
$172K 0.01%
+4,337
New +$206K
NGVC icon
782
Vitamin Cottage Natural Grocers
NGVC
$755M
$172K 0.01%
12,044
-1,019
-8% -$13.1K
GNK icon
783
Genco Shipping & Trading
GNK
$1.09B
$170K 0.01%
+10,649
New +$173K
HLX icon
784
Helix Energy Solutions
HLX
$1.33B
$169K 0.01%
54,039
DTIL icon
785
Precision BioSciences
DTIL
$175M
$165K 0.01%
742
-1,413
-66% -$395K
EVC icon
786
Entravision Communication
EVC
$1.01B
$164K 0.01%
+24,178
New +$183K
ONCR
787
DELISTED
Oncorus, Inc.
ONCR
$164K 0.01%
+31,191
New +$241K
FPH icon
788
Five Point Holdings
FPH
$396M
$159K 0.01%
+24,382
New +$165K
LYEL icon
789
Lyell Immunopharma
LYEL
$319M
$158K 0.01%
+1,024
New +$228K
PRDO icon
790
Perdoceo Education
PRDO
$2.14B
$152K 0.01%
+12,940
New +$141K
AFIB
791
DELISTED
Acutus Medical Inc
AFIB
$152K 0.01%
+44,474
New +$250K
HROW icon
792
Harrow
HROW
$1.46B
$150K 0.01%
17,342
-8,900
-34% -$87.9K
SUP
793
DELISTED
Superior Industries International
SUP
$150K 0.01%
33,568
+6,951
+26% +$36.7K
SXC icon
794
SunCoke Energy
SXC
$746M
$150K 0.01%
+22,766
New +$151K
FBP icon
795
First Bancorp
FBP
$4.47B
$147K 0.01%
+10,671
New +$147K
ANNX icon
796
Annexon
ANNX
$790M
$143K 0.01%
+12,415
New +$201K
RES icon
797
RPC Inc
RES
$1.13B
$143K 0.01%
31,600
+17,880
+130% +$87.8K
BNED icon
798
Barnes & Noble Education
BNED
$440M
$140K 0.01%
+206
New +$189K
TLIS
799
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$140K 0.01%
2,326
+319
+16% +$23.9K
VOXX
800
DELISTED
VOXX International Corporation Class A
VOXX
$138K 0.01%
+13,551
New +$151K

Similar funds

PDT Partners's Q4 2021 Portfolio in Review

As of Q4 2021, PDT Partners held 1,081 positions worth $1.31B, down 5.7% from $1.39B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

PDT Partners withdrew a net $105M in Q4 2021, closing 229 positions and reducing 286 holdings. Its most notable exit was MongoDB, an estimated $7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, PDT Partners opened a new position in Allakos worth $940K.

  • PDT Partners's largest Q4 2021 buy was Allakos: 96,046 shares worth $940K.
  • PDT Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021, an estimated $5.72M increase.
  • PDT Partners's biggest Q4 2021 reduction was Charles River Laboratories, cutting an estimated $6.37M.
  • PDT Partners fully exited MongoDB in Q4 2021, selling an estimated $7M.
  • PDT Partners's ten largest holdings make up 6.9% of its $1.31B portfolio in Q4 2021.
  • PDT Partners opened 330 new positions and closed 229 in Q4 2021.
  • PDT Partners's portfolio value fell 5.7% quarter-over-quarter to $1.31B.

Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.